Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Escalon Medical Corp. reported revenue of $12M, up 0.5% year over year. Operating margin was 1.1% and net margin 0.9%, on a free-cash-flow margin of 3.1% with capital expenditure at 0.0% of revenue. Every figure is computed directly from ESMC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $12M | 1.1% | 0.9% |
| FY2024 | $12M | -0.9% | -1.0% |
| FY2023 | $12M | 3.9% | 3.8% |
| FY2022 | $11M | -4.4% | 0.2% |
| FY2021 | $10M | -0.3% | -0.5% |
How does ESMC compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.